Table 1 Baseline characteristics of enrolled patients
Characteristics | Total patients (%) | Conversion surgery (%) |
|---|---|---|
n = 30 | n = 11 | |
Sex | ||
 Male | 14 (46.7%) | 5 (45.5%) |
 Female | 16 (53.3%) | 6 (54.5%) |
Age (years) | ||
 Median | 51 | 41 |
 Range | 29–74 | 29–74 |
ECOG score | ||
 0–1 | 28 (93.3%) | 11 (100%) |
 2 | 2 (6.7%) | 0 (0) |
Previous chemotherapy | ||
 Yes | 7 (23.3%) | 0 (0) |
 No | 23 (76.7%) | 11 (100%) |
Histological type | ||
 Poorly differentiated adenocarcinoma | 22 (73.3%) | 6 (54.5%) |
 Signet ring cell carcinoma | 8 (26.7%) | 5 (45.5%) |
Lauren’s type | ||
 Intestinal | 11 (36.7%) | 4 (36.7%) |
 Diffuse | 19 (63.7%) | 7 (63.7%) |
Extent of peritoneal metastases | ||
 P2 | 4 (13.3%) | 2 (18.2%) |
 P3 | 26 (86.7%) | 9 (81.8%) |
Ascites | ||
 Yes | 23 (76.7%) | 7 (63.6%) |
 No | 7 (23.3%) | 4 (36.4%) |
PCI score | ||
 0–9 | 5 (16.7%) | 3 (27.3%) |
 10–19 | 8 (26.7%) | 5 (45.4%) |
 20–39 | 17 (56.6%) | 3 (27.3%) |
Ovary metastasis | ||
 Yes | 7 (23.3%) | 3 (27.3%) |
 No | 23 (76.7%) | 8 (72.7%) |